A phase II/III Clinical Trial of Gecaxitinib Hydrochloride Tablets for the Treatment of Non-segmental Vitiligo in Adolescents and Adults Aged 12 and Above
Latest Information Update: 17 Jun 2024
At a glance
- Drugs Gecaxitinib hydrochloride (Primary)
- Indications Vitiligo
- Focus Therapeutic Use
Most Recent Events
- 17 Jun 2024 New trial record